Rossari Biotech Limited Stock

Equities

ROSSARI

INE02A801020

Specialty Chemicals

Market Closed - NSE India S.E. 07:43:49 2024-05-09 EDT 5-day change 1st Jan Change
714 INR +0.02% Intraday chart for Rossari Biotech Limited -4.70% -10.66%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 18.31B 219M 300M Sales 2025 * 20.91B 251M 343M Capitalization 39.45B 473M 647M
Net income 2024 1.31B 15.67M 21.44M Net income 2025 * 1.64B 19.72M 26.98M EV / Sales 2024 2.04 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.89 x
P/E ratio 2024
28.7 x
P/E ratio 2025 *
24 x
Employees 500
Yield 2024 *
0.43%
Yield 2025 *
0.36%
Free-Float 31.68%
More Fundamentals * Assessed data
Dynamic Chart
Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 MT
Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024
Rossari Biotech Limited Proposes Dividend for Fiscal Year 2023-2024 CI
Rossari Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Rossari Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Rossari Biotech Limited Appoints Sunil V as Chief Human Resource Officer, Effective April 15, 2024 CI
Rossari Biotech Limited Approves Incorporation of Wholly Owned Subsidiary in Dubai, United Arab Emirates CI
Transcript : Rossari Biotech Limited, Q3 2024 Earnings Call, Jan 23, 2024
Rossari Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Rossari Biotech Limited, Q2 2024 Earnings Call, Oct 23, 2023
Rossari Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Rossari Biotech Limited Appoints Esha Padmanabhan Achan as Additional Director Designated as Non-Executive, Independent Director with Effective October 21, 2023 CI
Rossari Biotech Incorporates Wholly-Owned Subsidiary in Bangladesh MT
Rossari Biotech Limited Announces Intimation of Incorporation of Rossari Bangladesh Limited, Wholly Owned Subsidiary CI
Transcript : Rossari Biotech Limited, Q1 2024 Earnings Call, Jul 31, 2023
More news
1 day+0.02%
1 week-4.70%
Current month-4.70%
1 month+0.29%
3 months-6.31%
6 months-0.45%
Current year-10.66%
More quotes
1 week
700.60
Extreme 700.6
756.00
1 month
700.60
Extreme 700.6
795.00
Current year
656.95
Extreme 656.95
836.00
1 year
656.95
Extreme 656.95
903.85
3 years
536.35
Extreme 536.35
1 619.00
5 years
536.35
Extreme 536.35
1 619.00
10 years
536.35
Extreme 536.35
1 619.00
More quotes
Managers TitleAgeSince
Founder 58 96-12-31
Founder 63 96-12-31
Director of Finance/CFO - 23-04-30
Members of the board TitleAgeSince
Director/Board Member 50 23-04-28
Founder 63 96-12-31
Founder 58 96-12-31
More insiders
Date Price Change Volume
24-05-09 714 +0.02% 48 875
24-05-08 713.8 -1.25% 40,389
24-05-07 722.9 -0.94% 56,153
24-05-06 729.8 +0.32% 174,600
24-05-03 727.4 -0.78% 113,908

Delayed Quote NSE India S.E., May 09, 2024 at 07:43 am

More quotes
Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
714 INR
Average target price
890.3 INR
Spread / Average Target
+24.70%
Consensus
  1. Stock Market
  2. Equities
  3. ROSSARI Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW